Business Wire

Enry's Island S.p.A. Becomes the First and Only Venture Builder in the World Listed on a Stock Exchange, After a €20M Round A

Share

Enry's Island S.p.A. is pleased to announce that it has successfully finalised its listing on the Vienna Stock Exchange - MTF, supported by PwC Austria, becoming the first and only Venture Builder in the world listed on a Stock Exchange.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230727222549/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Luigi Valerio Rinaldi Founder & Chairman of Enry's Island S.p.A. (Graphic: Business Wire)

“We are really proud of this incredible milestone,” says Luigi Valerio Rinaldi, Chairman & CEO of Enry's Island, “made possible thanks to the trust of internationally qualified operators, such as PwC Austria, supporting us in the Financial Due Diligence and Valuation phase, to successfully finalise the listing process on the Vienna Stock Exchange.

The listing on the VSE consolidates the internationality of the equity story and the scale-up phase of Enry's Island, one of the most interesting and innovative ecosystems on the global VC scene, explained by the following highlights:

  • a distributed corporate architecture, which includes Enry’s Island and its 5 Local Companies (distributed in UK, US, Africa, Italy), with an average of 30 Companies (including portfolio startups).
  • a unique holistic 3-layered framework, made of:
    • Business Layer: Enry's Model™ patented methodology, which later became the subject of economics manuals published by McGraw-Hill
    • Software Layer: HUI.land, a Super-App Saas used by each of the companies and stakeholders of the ecosystem, through which to manage every business function and process in the entire dealflow (from origination to fundraising)
    • Space Layer: Rinascimento5, the first phygital distributed coworking in the world, through which the community of Enry's Island can operate fully remotely;
  • an incredible growth in the quantity and quality of its economic, financial and equity indicators (increase in turnover of x2 in 2022 compared to 2021, which also continues in the first half of 2023, in which the turnover of 2022 has already been reached)
  • a large trust of qualified international investors, such as LDA Capital, a Los Angeles based fund with $11B in portfolio, which closed a €20M A Round with Enry's Island;
  • a success rate of its portfolio companies of 95% against the market average of 5%;
  • one of the first operators (not only among venture builders) to build its own headquarters in the metaverse, as early as 2021 and to have organised phygital investor days in the metaverse.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Investor relations:
emmanuelle.deba@enrysisland.com
0039 393 9774542

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Samsung Epis Holdings Delivers Business Updates at the 44th J.P. Morgan Healthcare Conference15.1.2026 02:40:00 EET | Press release

Samsung Epis Holdings (KRX: 0126Z0) today shared corporate progress and updates at the 44th J.P. Morgan Healthcare Conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114206458/en/ Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings "2026 is a monumental year for us, as we enter into a new chapter for our company. Today, we are announcing six additional candidates in our biosimilar pipeline, including vedolizumab and dupilumab. We are making great progress to secure 20 biosimilars in our portfolio by 2030," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We also received the investigational new drug application (IND) clearance for the first novel therapeutic candidate developed by Samsung Bioepis, and plan to advance our clinical program this year. As we broaden our portfolio beyond biosimilars, we will continue our development efforts in anti

Most Delivered Light-Entry Jet Cessna Citation M2 Gen2 With Garmin Autothrottles Enters Into Service, Bringing Greater Control and Precision to Pilots14.1.2026 21:30:00 EET | Press release

The Cessna Citation M2 Gen2 with Garmin Autothrottles recently entered into service. Certified by the Federal Aviation Administration in October 2025, the integration of Garmin’s Autothrottle system in the Citation M2 Gen2 further supports the most delivered light-entry jet’s capabilities by bringing greater control and precision to pilots. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114646844/en/ Most delivered light-entry jet Cessna Citation M2 Gen2 with Garmin Autothrottles enters into service, bringing greater control and precision to pilots (Photo Credit: Textron Aviation). The Cessna Citation M2 Gen2 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company. “We continue to invest in our products to provide customers with the best aviation experience in the world," said Lannie O’Bannion, senior vice president, Sales & Marketing. “The M2 Gen2 leads its segment as the most delivered

TwentyTwo Real Estate and Farallon Capital Complete €761 Million Investment in Isemia, a €1.2bn Healthcare Real Estate Company Created With emeis14.1.2026 19:30:00 EET | Press release

TwentyTwo Real Estate, an independent European real estate investment and management firm, announces the completion, alongside Farallon Capital, of a €761 million investment that led to the creation of Isemia (www.isemiabyemeis.com), a leading healthcare real estate company holding a €1.2 billion portfolio of assets operated by emeis. The transaction represents a significant milestone in TwentyTwo Real Estate’s long-term investment strategy focused on healthcare and operational living real estate. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114262830/en/ Fachklinik Schömberg Isemia comprises 68 high-quality assets across France, Germany and Spain, with a balanced mix of nursing homes (48%) and clinics (52%). The portfolio benefits from strong fundamentals and resilient operating performance. All properties will continue to be operated by emeis under long-term lease agreements, ensuring continuity of care for residents

AI’s Water Demand to Surge Nearly 130% by 2050 – New Research Shows How to Build a Water-Secure AI Economy14.1.2026 17:00:00 EET | Press release

The rapid global expansion of artificial intelligence is set to drive a 129% increase in water demand across the AI value chain by 2050, according to new research by Xylem (NYSE: XYL) and Global Water Intelligence (GWI). Watering the New Economy: Managing the Impacts of the AI Revolution provides the most comprehensive assessment to date of how AI is reshaping global water use. It also highlights practical ways to meet that demand while strengthening water security for communities. Spending on AI is forecast to approach $2 trillion in 2026,1 accelerating infrastructure build-out worldwide. By the middle of the century, this expansion is projected to add 30 trillion liters of water demand, annually, fueled by a surge in power generation (~54% of the increase), semiconductor fabrication (~42%), and data center expansion (~4%). Crucially, the report finds that this additional demand does not have to result in competition between industry and communities. Today, global water systems proces

Primient to Acquire Full Ownership of Primient Covation, LLC14.1.2026 17:00:00 EET | Press release

Primient, a global leader in biomanufacturing, announced today it has agreed to purchase the remaining ownership interest in Primient Covation, LLC (“Primient Covation”), establishing Primient as the sole owner of the company and marking an exciting new chapter in Primient’s growth in the bioeconomy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260114344080/en/ This acquisition is the next step of Primient’s strategy to strengthen Primient’s leadership position in biomanufacturing and builds upon recent announcements, including Primient’s partnership with Sustainea and the creation of the iPROOF venture. Primient Covation stands as a leading force in the U.S. biomanufacturing sector, distinguished by its broad range of biomanufacturing and fermentation expertise. The company was founded in 2000 to supply a variety of end markets, including cosmetics and personal care, textiles, fashion, coatings, functional fluids, and oth

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye